Drawing for BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE.

USPTO serial 78171946

BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE.

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
โ€”
Examiner
SUAREZ, MARIA VICTORIA
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BREAKTHROUGH SCIENCE. BREAKTHROUGH MEDICINE.?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nancy C. DiConza

DAVID EHRLICH FROSS ZELNICK LEHRMAN & ZISSU PC866 UNITED NATIONS PLZNEW YORK, NY 10017UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Prescription pharmaceutical preparations for use in the diagnosis or treatment of human diseases and disorders, namely, circulatory, respiratory, endocrine, neurologic, cardiovascular, alimentary, oncologic, auto-immune or immune-related, pulmonary, musculoskeletal, lymphatic, gastrointestinal, bone sensory, viral urinary, renal, infectious, metabolic or central nervous system diseases and disorders, excluding analgesics; diagnostic assays and test kits consisting primarily of reagents for clinical, laboratory, medical and chemical use to diagnose, prognose, predict or treat diseases and for providing genomic and proteomic profiles useful in the selection of therapeutics; assays and test kits consisting primarily of reagents for evaluating efficacy of treatments and treatment progress; prognostic test kits consisting primarily of reagents for identifying hereditary risk factors; diagnostic preparations, namely, preparations of extracts, assays, nucleic acids, proteins, polypeptides, and antibodies, and molecular arrays of biological materials for clinical or medical laboratory useACTIVEโ€”

Related trademarks

CopyMark links this record to cited ยง2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 18, 2007MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 18, 2007ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 19, 2007EX5GSOU EXTENSION 5 GRANTEDโ€”
Apr 3, 2007EXT5SOU EXTENSION 5 FILEDโ€”
Apr 3, 2007EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 16, 2006EX4GSOU EXTENSION 4 GRANTEDโ€”
Oct 5, 2006EXT4SOU EXTENSION 4 FILEDโ€”
Oct 5, 2006EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 14, 2006EX3GSOU EXTENSION 3 GRANTEDโ€”
Mar 23, 2006EXT3SOU EXTENSION 3 FILEDโ€”
Mar 23, 2006MAILPAPER RECEIVEDโ€”
Oct 20, 2005EX2GSOU EXTENSION 2 GRANTEDโ€”
Sep 30, 2005EXT2SOU EXTENSION 2 FILEDโ€”
Sep 30, 2005MAILPAPER RECEIVEDโ€”
Apr 18, 2005MAILPAPER RECEIVEDโ€”
Apr 12, 2005EX1GSOU EXTENSION 1 GRANTEDโ€”
Apr 12, 2005EXT1SOU EXTENSION 1 FILEDโ€”
Nov 29, 2004COARTEAS CHANGE OF OWNER ADDRESS RECEIVEDโ€”
Oct 19, 2004NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline โ€” usually six months from the notice date.
Aug 18, 2004ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATEDโ€”
May 21, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVEDโ€”
Jan 9, 2004ETOFEXTENSION OF TIME TO OPPOSE RECEIVEDโ€”
Dec 23, 2003PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 3, 2003NPUBNOTICE OF PUBLICATIONโ€”
Nov 4, 2003CNSAAPPROVED FOR PUB - PRINCIPAL REGISTERโ€”
Oct 15, 2003CFITCASE FILE IN TICRSโ€”
Sep 22, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICEโ€”
Sep 22, 2003MAILPAPER RECEIVEDโ€”
Mar 17, 2003CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 14, 2003DOCKASSIGNED TO EXAMINERโ€”

Frequently asked questions

Related guidance